516526-98-0Relevant articles and documents
PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORGAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
-
Page/Page column 36, (2012/11/06)
The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administrating these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo sulfonamide compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.
Development of a new sterically protecting auxiliary of the metacyclophane type and application to unsymmetrical diphosphenes, 1,3-diphosphaallene and 1,4-diphosphabutatriene
Toyota, Kozo,Nakamura, Akitake,Yoshifuji, Masaaki
, p. 3012 - 3013 (2007/10/03)
A new bulky bromobenzene of the metacyclophane type was converted to an unsymmetrically substituted 1,4-diphos-phabutatriene whose spin-spin coupling constant (3JPP) turned out to be larger, for the first time, than the 2J